Development of a Multipurpose Dashboard to Monitor the Situation of Emergency Departments
Launched by MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH · Apr 12, 2024
Trial Information
Current as of July 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring the development of a new dashboard designed to help emergency departments (EDs) manage patient flow more effectively. Emergency departments often see many patients at once, which can lead to long wait times and can affect the quality of care. The goal of this dashboard is to provide real-time information to both patients and healthcare providers. For patients, it can inform them about the current situation in their local ED and help them understand when it might be better to seek care elsewhere, especially for non-urgent issues. For healthcare providers, it will help them monitor patient care processes and identify any bottlenecks that could delay treatment.
To be eligible for this trial, participants need to be adults who arrive at the emergency department between January 1, 2025, and December 31, 2025. There are no specific health conditions required to take part. If you join the study, you can expect to contribute to the development of this important tool that aims to improve the efficiency of emergency care and potentially enhance patient outcomes. This trial is not yet recruiting participants, but it represents an exciting step toward better managing emergency healthcare services.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult
- • Arrived at emergency department between 1 January 2025 and 31 December 2025
- Exclusion Criteria:
- • - None
About Mario Negri Institute For Pharmacological Research
The Mario Negri Institute for Pharmacological Research is a leading Italian biomedical research organization dedicated to advancing pharmacological science and improving public health. Established in 1963, the Institute focuses on innovative research methodologies, drug development, and clinical trials aimed at understanding and treating various diseases. With a multidisciplinary team of scientists and clinicians, the Institute collaborates with national and international partners to translate research findings into clinical applications, contributing significantly to the fields of pharmacology, epidemiology, and biostatistics. Committed to excellence in research and ethical standards, the Mario Negri Institute plays a vital role in shaping the future of medical science and enhancing therapeutic strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Guido Bertolini, MD
Principal Investigator
Istituto Di Ricerche Farmacologiche Mario Negri
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported